Alps Advisors Inc Johnson & Johnson Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Alps Advisors Inc holds 228,216 shares of JNJ stock, worth $33 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
228,216
Previous 96,027 137.66%
Holding current value
$33 Million
Previous $14 Million 163.51%
% of portfolio
0.25%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$145.48 - $167.38 $19.2 Million - $22.1 Million
132,189 Added 137.66%
228,216 $37 Million
Q1 2024

May 14, 2024
SELL
$155.22 - $162.74 $107,567 - $112,778
-693 Reduced 0.72%
96,027 $15.2 Million
Q4 2023

Feb 14, 2024
BUY
$145.6 - $158.88 $80,080 - $87,384
550 Added 0.57%
96,720 $15.2 Million
Q3 2023

Nov 14, 2023
SELL
$155.75 - $174.48 $10.1 Million - $11.3 Million
-64,990 Reduced 40.33%
96,170 $15 Million
Q2 2023

Aug 14, 2023
SELL
$154.35 - $166.11 $627,124 - $674,904
-4,063 Reduced 2.46%
161,160 $26.7 Million
Q1 2023

May 10, 2023
SELL
$151.05 - $180.26 $3.22 Million - $3.84 Million
-21,309 Reduced 11.42%
165,223 $25.6 Million
Q4 2022

Feb 14, 2023
SELL
$160.2 - $179.79 $1.78 Million - $2 Million
-11,139 Reduced 5.64%
186,532 $33 Million
Q3 2022

Nov 14, 2022
SELL
$161.33 - $179.52 $9.75 Million - $10.9 Million
-60,450 Reduced 23.42%
197,671 $32.3 Million
Q2 2022

Aug 11, 2022
BUY
$168.19 - $186.01 $42.6 Million - $47.1 Million
253,237 Added 5185.03%
258,121 $45.8 Million
Q1 2022

May 16, 2022
SELL
$158.14 - $179.59 $180,121 - $204,553
-1,139 Reduced 18.91%
4,884 $866,000
Q4 2021

Feb 09, 2022
SELL
$155.93 - $173.01 $27.3 Million - $30.3 Million
-175,282 Reduced 96.68%
6,023 $1.03 Million
Q3 2021

Nov 15, 2021
SELL
$161.5 - $179.47 $197,999 - $220,030
-1,226 Reduced 0.67%
181,305 $29.3 Million
Q2 2021

Aug 11, 2021
SELL
$159.48 - $171.07 $7,655 - $8,211
-48 Reduced 0.03%
182,531 $30.1 Million
Q1 2021

May 07, 2021
SELL
$153.07 - $170.48 $1,836 - $2,045
-12 Reduced 0.01%
182,579 $30 Million
Q4 2020

Feb 03, 2021
SELL
$137.11 - $157.38 $30,986 - $35,567
-226 Reduced 0.12%
182,591 $28.7 Million
Q3 2020

Nov 04, 2020
SELL
$140.38 - $153.83 $57,696 - $63,224
-411 Reduced 0.22%
182,817 $27.2 Million
Q2 2020

Aug 05, 2020
SELL
$128.81 - $155.51 $3.78 Million - $4.56 Million
-29,339 Reduced 13.8%
183,228 $25.8 Million
Q1 2020

May 06, 2020
SELL
$111.14 - $153.99 $136,368 - $188,945
-1,227 Reduced 0.57%
212,567 $27.9 Million
Q4 2019

Feb 07, 2020
SELL
$127.5 - $146.44 $231,030 - $265,349
-1,812 Reduced 0.84%
213,794 $31.2 Million
Q3 2019

Nov 04, 2019
SELL
$126.95 - $142.14 $6.99 Million - $7.83 Million
-55,099 Reduced 20.35%
215,606 $27.9 Million
Q2 2019

Aug 07, 2019
SELL
$131.15 - $144.24 $316,202 - $347,762
-2,411 Reduced 0.88%
270,705 $37.7 Million
Q1 2019

May 01, 2019
BUY
$125.72 - $139.79 $234,090 - $260,288
1,862 Added 0.69%
273,116 $38.2 Million
Q4 2018

Feb 04, 2019
SELL
$122.84 - $147.84 $89,550 - $107,775
-729 Reduced 0.27%
271,254 $35 Million
Q3 2018

Oct 25, 2018
BUY
$121.58 - $142.88 $813,491 - $956,010
6,691 Added 2.52%
271,983 $37.6 Million
Q2 2018

Aug 02, 2018
BUY
$119.4 - $131.76 $664,461 - $733,244
5,565 Added 2.14%
265,292 $32.2 Million
Q2 2018

Jul 25, 2018
BUY
$119.4 - $131.76 $29.2 Million - $32.2 Million
244,667 Added 1624.61%
259,727 $36.3 Million
Q1 2018

May 01, 2018
BUY
$125.1 - $148.14 $667,158 - $790,030
5,333 Added 54.83%
15,060 $1.93 Million
Q4 2017

Feb 05, 2018
SELL
$131.22 - $143.62 $44.7 Million - $48.9 Million
-340,683 Reduced 97.22%
9,727 $1.36 Million
Q3 2017

Nov 03, 2017
BUY
$129.47 - $135.38 $45.4 Million - $47.4 Million
350,410
350,410 $45.6 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email